Market header image

Filings

Vous êtes ici

Lifestyle Delivery Systems Inc. announces Patent Filing for Advanced CannaStrips Formulations

novembre 29, 2016

Vancouver, British Columbia, Canada, November 29, 2016, Lifestyle Delivery Systems Inc. (CSE: LDS), (OTCQB: LDSYF), and Borse Frankfurt Exchange (XETR:LD6) (“LDS” or the “Company”) is proud to announce that the Company’s ongoing development of its CannaStrips Technology has resulted in the filing of a new patent. Our new patent is intended to act as the core patent for a future family of patents intended to establish new art in the area of sublingual, buccal membrane delivery of active ingredients into the blood stream. Chief Science Officer of LDS, Doctor John Sanderson, comments regarding the patent, “The subject matter of this patent, entitled Transmucosal Delivery of Biologically Active Agents, is a composition and method for delivering uniquely nano-encapsulated biological molecules of therapeutic value systemically - directly across mucous membranes - in order to achieve ease of administration, compliance, dose repeatability and improved bioavailability.” 

The patent includes specific and unique claims for any and all bioactives derived from Cannabis species. This embodiment teaches a composition that encapsulates cannabis extracts into defined nano-carriers (molecular chaperones) and then embeds these cannabinoid and terpene molecules into a colloid polymer thin film composition for efficient delivery across buccal mucous membranes with improved therapeutic effect, with fewer untoward or side effects, at lower cost. Brad Eckenweiler CEO of LDS, states, “The advancements that Dr. Sanderson has achieved will allow LDS to significantly differentiate the CannaStrips technology from any other delivery method currently available for any product worldwide.” The Company intends to incorporate these new innovations into the current product line in the first quarter of 2017.

About Lifestyle Delivery Systems Inc.

The Company’s technology produces infused strips (similar to breath strips) that are not only a safer, healthier option to smoking but also a new way to accurately meter the dosage and assure the purity of the product. From start to finish, the production process tests for quality and composition of all the ingredients used in each and every strip, resulting in a delivery system that is safe, consistent and effective.

On behalf of the board of directors of Lifestyle Delivery Systems Inc.

Brad Eckenweiler

CEO & Director

 

FOR MORE INFORMATION, PLEASE CONTACT:

investor.relations@lifestyledeliverysystem.com

1-866-347-5058

Cautionary Disclaimer Statement:

The Canadian Securities Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of the content of this news release.

Information set forth in this news release contains forward-looking statements that are based on assumptions as of the date of this news release. These statements reflect management’s current estimates, beliefs, intentions and expectations. They are not guarantees of future performance. The Company cautions that all forward looking statements are inherently uncertain and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Such factors include, among other things: risks and uncertainties relating to the Company’s limited operating history and the need to comply with environmental and governmental regulations. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward looking information. Except as required under applicable securities legislation, The Company undertakes no obligation to publicly update or revise forward-looking information.

 

 



CSE Listing(s):